Probiotic Supplementation to Reduce Necrotizing Enterocolitis and Mortality in Extremely Preterm Infants under 28 Weeks in Scandinavia
Led by Region Stockholm · Updated on 2023-10-16
1600
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether giving probiotics to extremely preterm infants born before 28 weeks of gestation can reduce the risk of necrotizing enterocolitis NEC, a serious intestinal disease, and neonatal death. This study is a double-blinded, randomized controlled trial involving 1620 extremely preterm infants at neonatal intensive care units in Sweden and Denmark. The goal is to provide evidence on the safety and effects of probiotic supplementation in this vulnerable group, which currently is not covered by clinical guidelines due to limited data.
Infants who tolerate at least 3 mL of breastmilk per feeding will receive a daily probiotic supplement called ProPrems, which contains specific strains of beneficial bacteria mixed with breastmilk. This treatment will continue until the infant reaches 34 weeks of gestational age. The control group will receive breastmilk alone without the probiotic supplement. The study is carefully blinded so that medical staff and researchers do not know which infants receive probiotics, ensuring unbiased results.
During the study, infants will be monitored for NEC and mortality up to 34 weeks gestational age plus 2 weeks, with secondary measures including sepsis, antibiotic use, hospital stay length, feeding tolerance, growth, and body composition after hospital discharge. Researchers will also collect stool samples to analyze gut microbiome development at multiple timepoints up to 12 months corrected age. Participation involves regular clinical assessments and data collection from medical records and neonatal quality registers, supporting a comprehensive evaluation of probiotic supplementation effects in extremely preterm infants.
CONDITIONS
Brief Title
Probiotic Supplementation in Extremely Preterm Infants in Scandinavia
Research Team
A
Alexander Rakow, MD PhD
S
Sofia Söderquist-Kruth
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
All extremely preterm infants born between gestational age 22+0 to 27+6 weeks
You will not qualify if you...
Patients with severe complications and low chance of survival detected within the first 72 hours of life
Patients with major congenital anomalies
Patients included in other interventional trials with the same or overlapping outcome measures
Your Study Journey
Screening
Duration - Up to 72 hours after birth
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Treatment
Duration - Approximately 8 to 14 weeks depending on gestational age at birth
Participants receive daily probiotic supplementation mixed with breastmilk or breastmilk alone via gastric tube starting when they tolerate at least 3 mL of breastmilk per meal until 34 weeks of gestational age.
Daily administration during hospital stay with ongoing clinical assessments
Follow-up
Duration - Up to 12 months corrected age after end of treatment
Participants are monitored for outcomes including feeding tolerance, growth, gut microbiome development, and survival up to 12 months corrected age.
Scheduled visits at 40 weeks gestational age, 12 months corrected age, and additional assessments during hospitalization
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Community Study to Monitor Disability Risk and Aging in Older Adults in Beijing
Using Biomarkers to Predict and Improve Outcomes After High-Risk Cardiac, Gastrointestinal, Vascular, and Lung Surgeries
Study of Extracellular Vesicles in Umbilical Cord Blood of Extremely Premature Newborns Born Before 28 Weeks and Their Link to Severe Health Problems
China Healthy Aging Cohort Study to Identify Risk Factors and Predict Disability and Dementia in Older Adults in China
Comparison of Very High-Power Short-Duration and Standard Low-Power Radiofrequency Ablation Techniques for Atrial Fibrillation Treatment
Evaluating Interleukin 6 Versus Procalcitonin to Detect Sepsis and Mortality in ICU Patients with Moderate to Severe Burns
Safety and Feasibility of a New Esophageal Stimulation and Oral Feeding Therapy for Infants With Complex Feeding Difficulties
Effects of Early and Regular Skin-to-Skin Care on Health Outcomes and Breastfeeding in Infants Born at or Before 32 Weeks
Comparing Mini-Crush and Controlled Balloon-Crush Stenting Techniques for Complex Coronary Bifurcation Lesions
Nanshan Elderly Cohort Study A Community-Based Study on Nutrition and Chronic Diseases in Shenzhen Residents Aged 65 and Older
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Probiotic supplementation and risk of necrotizing enterocolitis and mortality among extremely preterm infants-the Probiotics in Extreme Prematurity in Scandinavia (PEPS) trial: study protocol for a multicenter, double-blinded, placebo-controlled, and registry-based randomized controlled trial.
Sofia Söderquist Kruth, Carl Willers, Emma Persad...